Table 3.
Obesitya | Diabetesb | Hypertensiona | Elevated blood cholesterol and/or lipidsb | |||||
---|---|---|---|---|---|---|---|---|
AOR (95% CI) | p valuec | AOR (95% CI) | p valuec | AOR (95% CI) | p valuec | AOR (95% CI) | p valuec | |
ANA positivity | 0.99 | 0.73 | 0.66 | 0.71 | ||||
Negative (n = 756) | Reference | Reference | Reference | Reference | ||||
Weakly positive (n = 320) | 0.98 (0.71–1.35) | 0.86 (0.49–1.50) | 0.72 (0.47–1.10) | 1.13 (0.83–1.53) | ||||
Moderately or strongly positive (n = 53) | 1.00 (0.50–1.97) | 0.66 (0.19–2.28) | 1.00 (0.45–2.23) | 0.94 (0.50–1.77) |
ANA anti-nuclear autoantibody, AOR adjusted odds ratio, BMI body mass index, CI confidence interval
aObjectively measured weight and height and blood pressure (see Methods). Obesity was defined as BMI ≥ 30 kg/m2. Hypertension was defined as a systolic or diastolic blood pressure ≥ 140 mmHg and/or 90 mmHg, respectively
bSelf-reported information
cTests of fixed effects